Twelve Points Wealth Management LLC Decreases Stock Holdings in VanEck Pharmaceutical ETF (NASDAQ:PPH)

Twelve Points Wealth Management LLC lessened its stake in shares of VanEck Pharmaceutical ETF (NASDAQ:PPH) by 2.8% during the fourth quarter, HoldingsChannel.com reports. The fund owned 42,345 shares of the company’s stock after selling 1,231 shares during the quarter. VanEck Pharmaceutical ETF accounts for about 1.1% of Twelve Points Wealth Management LLC’s portfolio, making the stock its 18th biggest position. Twelve Points Wealth Management LLC’s holdings in VanEck Pharmaceutical ETF were worth $3,654,000 at the end of the most recent quarter.

A number of other large investors have also recently made changes to their positions in the stock. FMR LLC lifted its position in VanEck Pharmaceutical ETF by 12.5% during the third quarter. FMR LLC now owns 1,905 shares of the company’s stock valued at $181,000 after purchasing an additional 212 shares during the period. Edge Financial Advisors LLC bought a new position in shares of VanEck Pharmaceutical ETF during the 3rd quarter valued at $263,000. Grimes & Company Inc. purchased a new position in shares of VanEck Pharmaceutical ETF in the 4th quarter worth $310,000. Harbour Investments Inc. grew its holdings in shares of VanEck Pharmaceutical ETF by 16.6% in the third quarter. Harbour Investments Inc. now owns 3,425 shares of the company’s stock worth $325,000 after acquiring an additional 488 shares during the period. Finally, Townsquare Capital LLC increased its position in VanEck Pharmaceutical ETF by 3.8% during the third quarter. Townsquare Capital LLC now owns 3,519 shares of the company’s stock valued at $334,000 after acquiring an additional 130 shares during the last quarter.

VanEck Pharmaceutical ETF Stock Performance

Shares of NASDAQ:PPH opened at $88.85 on Wednesday. The stock’s 50-day simple moving average is $87.74 and its two-hundred day simple moving average is $91.90. The stock has a market capitalization of $581.08 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a 52-week low of $84.48 and a 52-week high of $99.51.

VanEck Pharmaceutical ETF Increases Dividend

The firm also recently disclosed a dividend, which was paid on Monday, December 30th. Investors of record on Friday, December 27th were issued a $0.411 dividend. This is an increase from VanEck Pharmaceutical ETF’s previous dividend of $0.36. The ex-dividend date was Friday, December 27th.

VanEck Pharmaceutical ETF Profile

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.